Cite
HARVARD Citation
James, I. et al. (2020). A First‐in‐Human Clinical Study With TRV734, an Orally Bioavailable G‐Protein–Biased Ligand at the μ‐Opioid Receptor. Clinical pharmacology in drug development. 9 (2), pp. 256-266. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
James, I. et al. (2020). A First‐in‐Human Clinical Study With TRV734, an Orally Bioavailable G‐Protein–Biased Ligand at the μ‐Opioid Receptor. Clinical pharmacology in drug development. 9 (2), pp. 256-266. [Online].